# HCPCS J1745: Injection, infliximab, 10mg

Medicare HCPCS J1745 has a Medicare Part B payment limit of $29.86 per 10 MG under 2026 Q4 Medicare Part B drug (ASP) pricing, the same in every state.

Web page: https://www.med-reveal.com/rates/J1745-hcpcs-fee-schedule
Section: Drugs and Biologicals
Billed by: Rheumatology

## Medicare rates

| | Amount |
| --- | --- |
| National non-facility | $29.86 |
| National facility | $29.86 |
| Release | 2026 Q4 (effective 2026-10-01) |

## Related codes

- J0129: Injection, abatacept, 10mg — https://www.med-reveal.com/rates/J0129-hcpcs-fee-schedule
- J0257: Injection, alpha1-proteinase inhibitor, 10mg — https://www.med-reveal.com/rates/J0257-hcpcs-fee-schedule
- J0490: Injection, belimumab, 10mg — https://www.med-reveal.com/rates/J0490-hcpcs-fee-schedule
- J0561: Injection, penicillin G benzathine, 100,000 units — https://www.med-reveal.com/rates/J0561-hcpcs-fee-schedule
- J0714: Injection, cefiderocol, 10mg — https://www.med-reveal.com/rates/J0714-hcpcs-fee-schedule
- J0885: Injection, epoetin alfa, non-ESRD use, 1000 units — https://www.med-reveal.com/rates/J0885-hcpcs-fee-schedule
- J0897: Injection, denosumab, 1mg — https://www.med-reveal.com/rates/J0897-hcpcs-fee-schedule
- J1300: Injection, eculizumab, 10mg — https://www.med-reveal.com/rates/J1300-hcpcs-fee-schedule

Commercial negotiated rates for J1745 by payer and state: https://www.med-reveal.com/solutions/rate-benchmarking

## Sources

- CMS Medicare fee schedules (2026 Q4): https://www.cms.gov/medicare/payment/fee-schedules